varespladib has been researched along with Amyotonia Congenita in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantuaria, NM; Cogo, JC; de Souza, J; Floriano, RS; Gutiérrez, JM; Hyslop, S; Oliveira, ICF; Oshima-Franco, Y; Silva Junior, NJ; Torres-Bonilla, KA; Yoshida, EH | 1 |
| Fontana Oliveira, IC; Gutiérrez, JM; Lewin, MR; Oshima-Franco, Y | 1 |
2 other study(ies) available for varespladib and Amyotonia Congenita
| Article | Year |
|---|---|
Effect of the phospholipase A
Topics: Acetates; Animals; Antivenins; Crotalid Venoms; Crotoxin; Drug Synergism; Indoles; Keto Acids; Mice; Neuromuscular Blockade; Neuromuscular Diseases; Phospholipases A2 | 2022 |
Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation.
Topics: Acetates; Antivenins; Elapid Venoms; Indoles; Keto Acids; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Junction; Neurotoxicity Syndromes; Neurotoxins; Snake Bites | 2020 |